To help ensure compliance with external regulatory quality and safety standards, and support the continuous improvement of our quality management system, Novartis has a robust and independent audit program that covers the product lifecycle. Travel restrictions introduced by the COVID-19 pandemic resulted in business disruptions across Novartis and our external partners globally.